
Loading, please wait...

Loading, please wait...

First-time seizures in adults often pose a significant diagnostic challenge for clinicians. While these events typically suggest epilepsy or acute physiological triggers, a recent study indicates that first-time seizure cancer risk might be a critical indicator of an undiagnosed malignancy. Specifically, this research suggests these neurological events may signal occult cancers long before other symptoms appear.
A population-based cohort study in Denmark analyzed nearly 50,000 adults who experienced a first hospital-diagnosed seizure. Notably, researchers found a sharp increase in cancer diagnoses immediately following the seizure event. Furthermore, within the first year, the standardized incidence ratio (SIR) for any cancer was 5.30. Consequently, the relative risk of cancer is five times higher than that of the general population in the initial twelve months. In addition, the risk was most pronounced for neurological cancers, such as primary brain tumors, which showed an SIR of 76.1.
Moreover, the risk for nonneurological cancers was also elevated, reaching an SIR of 2.32 in the first year. Although the relative risk peaks early, it remains slightly higher than average for up to 20 years. Therefore, clinicians must consider broader diagnostic assessments for adults presenting with new-onset seizures, especially those without a clear etiology.
Early detection of occult cancers through comprehensive screening could potentially improve patient outcomes. Because the first-time seizure cancer risk extends beyond the brain, screening should ideally include assessments for systemic malignancies. Maintaining long-term clinical vigilance is essential, as the risk persists even years after the initial neurological event.
Yes, research shows that first-time seizures are associated with a two-fold increase in the risk of nonneurological cancers, such as lung or breast cancer, within the first year. These seizures may occur due to metabolic disturbances or paraneoplastic syndromes related to systemic malignancy.
The highest risk occurs within the first year of the seizure event. However, studies have observed a slightly elevated risk for both neurological and nonneurological cancers for up to 20 years post-seizure, suggesting a need for sustained clinical monitoring.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or establish a doctor-patient relationship. Refer to the latest local and national guidelines for clinical practice.
References
Pedersen AL et al. Risk of Cancer in Patients With First-Time Seizure. JAMA Neurol. 2026 Apr 27. doi: 10.1001/jamaneurol.2026.0894. PMID: 42043826.
Maschio M. Seizure Prognosis in Brain Tumors: New Insights and Evidence-Based Management. PMC. 2012.
Vecht CJ. Seizures and epilepsy in oncological practice: causes, course, mechanisms and treatment. Journal of Neurology, Neurosurgery, and Psychiatry. 2007.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A Danish cohort study reveals that first-time seizures may be early clinical signs of occult cancers, both neurological and nonneurological....
4 months ago

A new study reveals that lipid-related metabolic dysregulation, marked by elevated TG/HDL-C ratio and glymphatic changes, independently impacts survival in idiopathic normal pressure hydrocephalus.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

A meta-analysis of 13 propensity score-matched studies shows ViV-TAVR delivers lower early mortality and reduced bleeding compared to redo-SAVR for degenerated bioprosthetic aortic valves, though long-term hemodynamics warrant careful anatomical and patient-centered evaluation.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today